N

Natera

Makes genetic tests for clinical care

Medical Director - Skin/IO

Biology & BiotechConfirmed live in the last 24 hours
Full-timeRemote in USA

About the Job

Requirements

  • An MD or DO degree and board certification in Medical Oncology are required.
  • At least 5 years of oncology experience, with clinical or research experience in melanoma, skin cancers, or immunotherapy, is preferred.
  • A strong publication or clinical trial background in immuno-oncology or translational oncology research is preferred.
  • Ability to rapidly learn Natera’s molecular testing technologies and apply clinical judgment to evaluate and communicate their relevance.
  • Strong written and verbal communication skills, including scientific presentation and education.
  • Demonstrated success working cross-functionally with commercial, research and development, and clinical teams.
  • Understanding of immuno-oncology trial design, translational endpoints, and regulatory considerations.
  • Effective project management and ability to balance multiple high-impact initiatives.

Responsibilities

  • Lead clinical strategy and evidence generation for melanoma, non-melanoma skin cancers, and pan-tumor immunotherapy indications.
  • Partner with clinical development, medical affairs, and commercial teams to translate emerging evidence into clinical practice applications.
  • Collaborate with key opinion leaders, cooperative groups, and academic investigators to validate and expand clinical use cases for ctDNA-based diagnostics in immuno-oncology.
  • Provide field-facing education and strategic guidance to healthcare providers, payers, and advocacy organizations on clinical utility, interpretation, and the impact of MRD and response monitoring in immune-treated populations.
  • Identify and address adoption barriers by aligning evidence generation, messaging, and stakeholder engagement with standards of care and health system needs.
  • Serve as the medical and scientific spokesperson for skin and immuno-oncology programs, communicating clinical utility, study data, and product value to external experts and stakeholders.
  • Partner with commercial teams to develop educational resources, medical content, and scientific training for healthcare providers and internal teams.
  • Provide scientific leadership during advisory boards, symposia, and investigator meetings.
  • Represent Natera at national and international oncology and immunotherapy conferences and foster relationships with key opinion leaders in melanoma and immuno-oncology.
  • Promote scientific rigor and innovation within the medical affairs and research and development organizations.
  • Collaborate on clinical trial design, data analysis, and publication strategy related to ctDNA applications in melanoma and other immune-responsive solid tumors.
  • Identify and cultivate academic and cooperative group partnerships to advance clinical validation and translational research in skin and pan-tumor immuno-oncology.
  • Provide expert medical guidance on immunotherapy-specific diagnostic development and clinical implementation.
  • Engage across tumor types to support Natera’s broad oncology portfolio.
  • Maintain awareness of emerging trends in liquid biopsy, precision medicine, and immune response monitoring.
  • Work collaboratively with research, development, commercial, and medical affairs teams to align medical strategy with business objectives.
  • Partner with regulatory and clinical operations teams to ensure compliance, data quality, and clinical relevance.

About the Company

Natera

Makes genetic tests for clinical care

Natera develops genetic tests for clinicians caring for people with cancer, inherited conditions, pregnancies, and organ transplants, using DNA analysis to inform medical decisions. Its portfolio includes Signatera for tracking residual cancer, Panorama for prenatal screening, and Prospera for assessing transplanted organ health. The company combines laboratory analysis with software that distinguishes DNA fragments in blood, and earns revenue mainly from diagnostic testing, alongside licensing and services for research partners. Clinicians use its portals to order tests, track samples, and review results, while patients have access to genetic information sessions. Natera was founded in 2004 and is headquartered in Austin, Texas.

Company size
5,001-10,000
Company stage
IPO
Headquarters
Austin, TX
Founded
2004

Recently Posted Jobs

Explore more opportunities at Natera

See more jobs